|1.||Wang, Mei: 3 articles (09/2014 - 07/2008)|
|2.||Casey, Patrick J: 3 articles (09/2014 - 03/2005)|
|3.||Lee, How Sung: 2 articles (02/2009 - 07/2008)|
|4.||Zhou, Jin: 2 articles (02/2009 - 07/2008)|
|5.||Ramanujulu, Pondy M: 1 article (09/2014)|
|6.||Guo, Dianyan: 1 article (09/2014)|
|7.||Lau, Hiu Yeung: 1 article (09/2014)|
|8.||Wirawan, Melissa: 1 article (09/2014)|
|9.||Go, Mei-Lin: 1 article (09/2014)|
|10.||Yang, Tianming: 1 article (09/2014)|
09/02/2010 - "Further, treatment of mice-bearing HepG2-derived tumors with cysmethynil resulted in marked inhibition of tumor growth; analysis of tumor tissue from these mice revealed markers consistent with autophagy induction and cell growth arrest."
07/04/2008 - "Screening of a diverse chemical library led to the identification of a specific small molecule inhibitor of Icmt, cysmethynil, that inhibited growth factor signaling and tumorigenesis in an in vitro cancer cell model (Winter-Vann, A. "
09/01/2014 - "Consistent with its greater in vitro efficacy, compound 8.12 inhibited tumor growth with greater potency than cysmethynil in a xenograft mouse model. "
02/15/2009 - "Cysmethynil causes cell death in many human cancer cells in vitro, and inhibits tumor growth in the xenograft mouse model in vivo. "
07/04/2008 - "Further, the dual effects of cell death and cell cycle arrest by cysmethynil treatment strengthen the rationale for targeting Icmt in cancer chemotherapy."
|2.||Colonic Neoplasms (Colon Cancer)
|1.||Epidermal Growth Factor (EGF)
|1.||Heterologous Transplantation (Xenotransplantation)
|2.||Drug Therapy (Chemotherapy)